{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:16:17Z","timestamp":1767147377277,"version":"build-2238731810"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023450","name":"Information and Communications Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023450","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Americas"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.lana.2025.101172","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:54:59Z","timestamp":1751432099000},"page":"101172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical and economic impact of the availability of innovative therapies for advanced lung cancer in men in Latin America: a population-based secondary data study"],"prefix":"10.1016","volume":"49","author":[{"given":"Andr\u00e9s F.","family":"Cardona","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Guti\u00e9rrez-Babativa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jairo","family":"Zuluaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Viola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5915-0052","authenticated-orcid":false,"given":"Carlos","family":"Carvajal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Bogoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Prieto-Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0782-4315","authenticated-orcid":false,"given":"Daniel","family":"Samac\u00e1-Samac\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1080-3926","authenticated-orcid":false,"given":"Antonio","family":"Robles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Kock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Corrales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis E.","family":"Raez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3955-1101","authenticated-orcid":false,"given":"Vladmir","family":"Cordeiro de Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suraj","family":"Samtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1164-3779","authenticated-orcid":false,"given":"Oscar","family":"Arrieta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lana.2025.101172_bib1","series-title":"Cancer today WHO","year":"2024"},{"issue":"12","key":"10.1016\/j.lana.2025.101172_bib3","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1080\/13696998.2020.1834403","article-title":"Changes in mortality associated with cancer drug approvals in the United States from 2000 to 2016","volume":"23","author":"MacEwan","year":"2020","journal-title":"J Med Econ"},{"issue":"5","key":"10.1016\/j.lana.2025.101172_bib4","article-title":"Assessment of the clinical and cost-effectiveness evidence in the reimbursement decisions of new cancer drugs","volume":"7","author":"Strand","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.lana.2025.101172_bib5","series-title":"Are cancer drugs worth the price? the effects of pharmaceutical innovation on cancer mortality rates","author":"Dubois","year":"2016"},{"key":"10.1016\/j.lana.2025.101172_bib6","series-title":"Global oncology trends 2022","volume":"vol. 65","year":"2022"},{"issue":"1","key":"10.1016\/j.lana.2025.101172_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cllc.2023.10.007","article-title":"Lung cancer in women: the past, present, and future","volume":"25","author":"Florez","year":"2024","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"10.1016\/j.lana.2025.101172_bib9","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.lana.2025.101172_bib10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1916623","article-title":"The effect of advances in lung-cancer treatment on population mortality","volume":"383","author":"Howlader","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lana.2025.101172_bib11","article-title":"Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysis","volume":"22","author":"Ivama-Brummell","year":"2023","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.lana.2025.101172_bib12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.radonc.2022.06.001","article-title":"The effect of delayed primary treatment initiation on adverse events and recurrence in older head and neck cancer patients","volume":"173","author":"Schoonbeek","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.lana.2025.101172_bib13","article-title":"Mortality due to cancer treatment delay: systematic review and meta-analysis","volume":"371","author":"Hanna","year":"2020","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.lana.2025.101172_bib14","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.3390\/curroncol31030110","article-title":"Impact of systemic delays for patient access to oncology drugs on clinical, economic, and quality of life outcomes in Canada: a call to action","volume":"31","author":"Sehdev","year":"2024","journal-title":"Curr Oncol"},{"key":"10.1016\/j.lana.2025.101172_bib15","series-title":"W.A.I.T indicator 2023 \u2013 Latin America","year":"2024"},{"key":"10.1016\/j.lana.2025.101172_bib16","series-title":"FIFARMA patient W.A.I.T. Indicator 2024 - Am\u00e9rica Latina","year":"2023"},{"key":"10.1016\/j.lana.2025.101172_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102017","article-title":"Bevacizumab (Avastin\u00ae) in cancer treatment: a review of 15 years of clinical experience and future outlook","volume":"86","author":"Garcia","year":"2020","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"10.1016\/j.lana.2025.101172_bib18","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s43441-023-00565-7","article-title":"Comparison of the Latin America regulation landscape and international reference health authorities to hasten drug registration and clinical research applications","volume":"57","author":"Argotti","year":"2023","journal-title":"Therap Innov Regul Sci"},{"issue":"4","key":"10.1016\/j.lana.2025.101172_bib19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1057\/s41271-020-00245-y","article-title":"Registration pathways to accelerate regulatory assessment of innovative medicines in Latin America","volume":"41","author":"Padua","year":"2020","journal-title":"J Publ Health Pol"},{"key":"10.1016\/j.lana.2025.101172_bib21","series-title":"Global burden of disease (GBD)","year":"2019"},{"key":"10.1016\/j.lana.2025.101172_bib22","series-title":"Forum for health economics and policy","article-title":"The effect of pharmaceutical innovation on longevity: patient level evidence from the 1996\u20132002 medical expenditure panel survey and linked mortality public-use files","year":"2013"},{"issue":"1","key":"10.1016\/j.lana.2025.101172_bib23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s40503-017-0045-6","article-title":"The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003\u20132013","volume":"26","author":"Lichtenberg","year":"2017","journal-title":"Latin Am Econ Rev"},{"issue":"3","key":"10.1016\/j.lana.2025.101172_bib24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1017\/dem.2018.11","article-title":"The impact of new drug launches on life-years lost in 2015 from 19 types of cancer in 36 countries","volume":"84","author":"Lichtenberg","year":"2018","journal-title":"J Demogr Econ"},{"issue":"5","key":"10.1016\/j.lana.2025.101172_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/inthealth\/ihz003","article-title":"How many life-years have new drugs saved? A three-way fixed-effects analysis of 66 diseases in 27 countries, 2000\u20132013","volume":"11","author":"Lichtenberg","year":"2019","journal-title":"Int Health"},{"key":"10.1016\/j.lana.2025.101172_bib26","series-title":"Socioeconomic burden of main diseases in eight Latin American countries","author":"Hernandez-Villafuerte","year":"2024"},{"issue":"1","key":"10.1016\/j.lana.2025.101172_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41571-022-00700-7","article-title":"Barriers in access to oncology drugs\u2014a global crisis","volume":"20","author":"Barrios","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.lana.2025.101172_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.11606\/s1518-8787.2024058005704","article-title":"Smoking, mortality, access to diagnosis, and treatment of lung cancer in Brazil","volume":"58","author":"Campos","year":"2024","journal-title":"Rev Saude Publica"},{"key":"10.1016\/j.lana.2025.101172_bib29","series-title":"Lung cancer: the cost of inaction in Latin America","year":"2022"},{"issue":"2","key":"10.1016\/j.lana.2025.101172_bib30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jtho.2024.10.016","article-title":"Lung cancer in Argentina","volume":"20","author":"Rizzo","year":"2025","journal-title":"J Thorac Oncol"},{"issue":"8","key":"10.1016\/j.lana.2025.101172_bib31","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/ijc.34129","article-title":"Survival, cost and added therapeutic benefit of drugs granted early access through the French temporary authorization for use program in solid tumors from 2009 to 2019","volume":"151","author":"Pham","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lana.2025.101172_bib32","first-page":"e10","article-title":"Regulatory reliance to approve new medicinal products in Latin American and Caribbean countries","volume":"45","author":"Dur\u00e1n","year":"2021","journal-title":"Rev Panam Salud P\u00fablic"},{"key":"10.1016\/j.lana.2025.101172_bib33","series-title":"Statement from global medicines regulators on the value of regulatory reliance","year":"2021"},{"key":"10.1016\/j.lana.2025.101172_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-018-1017-7","article-title":"Adaptive designs in clinical trials: why use them, and how to run and report them","volume":"16","author":"Pallmann","year":"2018","journal-title":"BMC Med"},{"issue":"4","key":"10.1016\/j.lana.2025.101172_bib35","first-page":"327","article-title":"Global trends of lung cancer mortality and smoking prevalence","volume":"4","author":"Islami","year":"2015","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.lana.2025.101172_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2023.108128","article-title":"Indoor wood-burning from stoves and fireplaces and incident lung cancer among Sister Study participants","volume":"178","author":"Mehta","year":"2023","journal-title":"Environ Int"}],"updated-by":[{"DOI":"10.1016\/j.lana.2025.101300","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000}}],"container-title":["The Lancet Regional Health - Americas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X25001826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X25001826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T08:08:35Z","timestamp":1757664515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667193X25001826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":33,"alternative-id":["S2667193X25001826"],"URL":"https:\/\/doi.org\/10.1016\/j.lana.2025.101172","relation":{},"ISSN":["2667-193X"],"issn-type":[{"value":"2667-193X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and economic impact of the availability of innovative therapies for advanced lung cancer in men in Latin America: a population-based secondary data study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Americas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lana.2025.101172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101172"}}